Učitavanje...
Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia
BACKGROUND: We evaluated if the survival benefit of adding rituximab to standard chemotherapy for non-Hodgkin lymphoma (NHL) observed in clinical trials has been experienced by an Australian NHL patient population. METHODS: NHL cases diagnosed in 1985-2004 in New South Wales (NSW) were followed-up t...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2010
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2886045/ https://ncbi.nlm.nih.gov/pubmed/20497580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-231 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|